medigraphic.com
SPANISH

Revista Cubana de Medicina Tropical

ISSN 1561-3054 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 2

<< Back Next >>

Rev Cubana Med Trop 2014; 66 (2)

Antiviral activity of an aqueous extract from the red alga Laurencia obtusa against influenza A and B viruses

Pérez-Riverol A, Piñón RA, Morier DLF, Torres LY, Mendoza LD, del Barrio AG
Full text How to cite this article

Language: Spanish
References: 36
Page: 273-285
PDF size: 267.48 Kb.


Key words:

influenza, antiviral, Laurencia obtusa, natural extracts, algae.

ABSTRACT

Introduction: antiviral therapy against infections caused by influenza viruses is based on the use of inhibitors of M2 protein and neuraminidase (NA). However, the emergence of seasonal strains resistant to both drug groups has led to the search for new anti-influenza medications. Extracts from algae may be used as a source of compounds, considering the diversity of metabolites described for these organisms.
Objective: evaluate the in vitro antiviral activity of an aqueous extract from the red alga Laurencia obtusa against influenza A (H1N1), A (H3N2) and B viruses.
Methods: cytotoxicity was evaluated in MDCK cells by cell viability estimation in the presence of growing concentrations of the extract. The effects over viral replication were quantified by determining hemagglutinin (HA) levels and inhibition of the cytopathic effect (CPE). The selective index (SI) was estimated by SI=CC50/CE50.
Results: the aqueous extract of Laurencia obtusa showed in vitro antiviral activity against influenza B, A (H3N2) and A (H1N1) viruses with SI values of 7.73, 11.79 and 12.95, respectively.
Conclusions: Laurencia obtusa inhibits the replication of influenza viruses, a fact of great clinical importance. Secondary assays to characterize the biological activity and molecular composition of the extract may lead to the development of novel antiviral compounds. The present paper is the first report on the inhibitory activity of this macroalga species against influenza viruses.


REFERENCES

  1. Gripe estacional. Nota descriptiva, No 211. [Citado enero 2012]. Disponible en: http://www.who.int/mediacentre/factsheets/fs211/en/index.html

  2. Kanga SM, Songa JM, Compans RW. Novel vaccines against influenza viruses. Virus Research. 2011;162:31-38.

  3. Pizzorno AS, Abed Y, Boivin G. Influenza Drug Resistance. Seminars in Respiratory and Critical Care Medicine. 2011;32:409-422.

  4. Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, et al. Surveillance of Resistance to Adamantanes Among Influenza A (H3N2) and A (H1N1) Viruses Isolated Worldwide. J Infect Dis. 2007;(196):249-255.

  5. Gubareva LV, Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten R, Xu X. Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008. Antimicrob Agents Chemother. 2008;52(9):3284-3292.

  6. Piñón A, Herrera A, Valdés O, Pérez A, Arencibia A, Savón C, et al. Adamantane and neuraminidase inhibitor resistance among circulating human influenza A viruses in Cuba during 2006-2010. Int J Antimicrob Agents. 2013;49:94-99.

  7. El Gamal AA. Biological importance of marine algae. Saudi Pharmaceutical J. 2010;18:1-25.

  8. Talarico LB, Pujol CA, Zibetti RGM, Faría PC, Noseda MD, Duarte ME. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Research. 2005;66:103-110.

  9. Mori T, O'Keefe BR, Sowder RC, Bringans S, Gardella R, Berg S. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem. 2005;280:9345-9353.

  10. Hayashi K. Lee JB, Nakano T, Hayashi T. Anti-influenza A virus characteristics of a fucoidan from sporophyll of Undaria pinnatifida in mice with normal and compromised immunity. Microbes and Infection. 2013;15:302-309.

  11. Chen M, Xie H, Yang L, Liao Z, Yu J. In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis. Virologica Sinica. 2010;25(5):341-351.

  12. Sato Y, Morimoto K, Hirayama M, Hori K. High mannose-specific lectin (KAA-2) from the red alga Kappaphycus alvarezii potently inhibits influenza virus infection in a strain-independent manner. Biochemical and Biophysical Research Communications. 2011;405:291-296.

  13. Sato Y, Hirayama M, Morimoto K, Yamamoto N, Okuyama S, Hori K. High mannose-binding lectin with preference for the cluster of alpha1-2-mannose from the green alga Boodlea coacta is a potent entry inhibitor of HIV-1 and influenza viruses. J Biol Chem. 2011;286:19446-19458.

  14. da S Machado F, Kaiser C, Costa S, Gestinari L, Soares A. Atividade biológica de metabólitos secundários de algas marinhas do gênero Laurencia. Braz J Pharmacognosy. 2010;20(3):441-452.

  15. Johnson M, Babu A, Janakiraman R, Malar T. Phytochemical studies on Laurencia obtusa (Hudson) Lamourux. Int J Biomed Adv Res. 2012;3(4):225-232.

  16. Alarif W, Al-Lihaibi S, Ayyad SE, Abdel-Rhman M, Badria F. Laurene-type sesquiterpenes from the Red Sea red alga Laurencia obtuse as potential antitumor and antimicrobial agents. Europ J Med Chem. 2012;55:462-466.

  17. Mendiola-Martínez J, Hernández H, Acuña D, Esquivel M, Scull-Lizama R, Abreu-Payrol J. Actividad inhibidora del crecimiento in vitro de Plasmodium falciparum de extractos de algas del género Laurencia. Rev Cubana Med Trop. 2005;57(3):192-195.

  18. Littler DS, Littler MM. Rhodophytes (Red Algae). En: Littler DS eds. Caribbean Reef Plants. Washington, USA. Off Shore Graphics; 2000:201-221.

  19. Shiomi K, Kamiya H, Shimizu Y. Purification and characterization of an agglutinin in the red alga Agardhiella tenera. Biochim Biophyc Acta. 1979;576:118-127.

  20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 1983;(65):55-63.

  21. del Barrio G, Parra F. Evaluation of the antiviral activity of an aqueous extract from Phyllantus orbicularis. J Etnopharmacol. 2010;(72):317:322.

  22. Alvarez AL, del Barrio G, Kourí V, Martínez PA, Suárez B, Parra F. In vitro antiherpetic activity of an aqueous extract from the plant Phyllanthus orbicularis. Phytomedicine. 2009;16(10):960-966.

  23. WHO. Manual for the laboratory and virological surveillance of influenza. Suiza. WHO Press. 2010.

  24. Anuario estadístico de salud. MINSAP. 2012. [Citado diciembre 2012]. Disponible en: http://files.sld.cu/dne/files/2013/04/anuario2012.pdf

  25. Iliopoulou D, Roussis V, Pannecouque C, De Clercq E, Vagias C. Halogenated sesquiterpenes from the red alga Laurencia obtusa. Tetrahedron. 2002;58:6749- 6755.

  26. Ogura F, Hashayi K, Lee JB, Kanekiyo K, Hashayi T. Evaluation of an Edible Blue-Green Alga, Aphanotece sacrum, for Its Inhibitory Effect on Replication of Herpes Simplex Virus Type 2 and Influenza Virus Type A. Bioscience, Biotechnology, and Biochemistry. 2010;74(8):1687-1690.

  27. Vanden Berghe A, Vlietinck AJ, Van Hoof L. Plant products as potential antiviral agents. Bull. Pasteur Institute. 1986;84:101-147.

  28. Serkedjieva J. Antiviral Activity of the Red Marine Alga Ceramium rubrum. Phytother. Res. 2004;18: 480-483.

  29. Nzembi Makau J, Watanabe K, Kobayashi K. Anti-influenza activity of Alchemilla mollis extract: Possible virucidal activity against influenza virus particles. Drug Discoveries & Therapeutics. 2013;7(5):189-195.

  30. Wang H, Fu C, Li K, Lu J, Chen Y, Lu E, et al. Influenza associated mortality in Southern China, 2010-2012. Vaccine. 2013; doi: 0.1016/j.vaccine.2013.12.013.

  31. Thompson W, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;(289):179-186.

  32. Saha RK, Takahashi T, Kurebayashi Y, Fukushima K, Minami A, Kinbara N, et al. Antiviral effect of strictinin on influenza virus replication. Antiviral Research. 2010;(88):10-18.

  33. Ueda K, Kawabata R, Irie T, Nakai Y, Tohya Y, Sakaguchi T. Inactivation of Pathogenic Viruses by Plant-Derived Tannins: Strong Effects of Extracts from Persimmon (Diospyros kaki) on a Broad Range of Viruses. PlosOne. 2013;8(1):e55343.

  34. Ryu YB, Jae-Jeong H, Young-Yoon S, Park JY, Min- Kim Y, Park SY, et al. Influenza Virus Neuraminidase Inhibitory Activity of Phlorotannins from the Edible Brown Alga Ecklonia cava. J Agric Food Chem. 2011;(59):6467-6473.

  35. Ding N, Chen Q, Zhang W, Ren S, Guo Y, Li Y. Structure-activity relationships of saponin derivatives: A series of entry inhibitors for highly pathogenic H5N1 influenza virus. Europ J Med Chem. 2012;(53):316-326.

  36. Patil D, Roy S, Dahake R, Rajopadhye S, Kothari S, Deshmukh R, Chowdhary A. Evaluation of Jatropha curcas Linn. Leaf extracts for its cytotoxicity and potential to inhibit hemagglutinin protein of influenza virus. Indian J Virol. 2013;24(2):220-226.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Med Trop. 2014;66